Sarepta Therapeutics (SRPT) Posts Wider Q4 Loss; NDA Submission for Eteplirsen Planned for Mid-Year 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. WYFI
5. EAT
6. GO
7. STUB
8. NBIS
9. CRS
10. ARX

Go back to Sarepta Therapeutics (SRPT) Posts Wider Q4 Loss; NDA Submission for Eteplirsen Planned for Mid-Year 2015
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 18.31 -0.07 (0.38%)
Previous Close $18.38    52 Week High $63.73 
Open $18.41    52 Week Low $8.00 
Day High $18.61    P/E N/A 
Day Low $18.20    EPS $-5.69 
Volume 162,033